Načítá se...

A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis

BACKGROUND: Approximately 80% - 90% of individuals infected with latent Mycobacterium tuberculosis (Mtb) remain protected throughout their life-span. The release of unique, latent-phase antigens are known to have a protective role in the immune response against Mtb. Although the BCG vaccine has been...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Infect Dis
Hlavní autoři: Maurya, Sudeep Kumar, Aqdas, Mohammad, Das, Deepjyoti Kumar, Singh, Sanpreet, Nadeem, Sajid, Kaur, Gurpreet, Agrewala, Javed Naim
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495405/
https://ncbi.nlm.nih.gov/pubmed/32942991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05372-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!